Concepedia

James D. Bergstrom

JD

49

Publications

5.6K

Citations

31

H-Index

1979

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of California, Los Angeles

United States Military Academy

James D. Bergstrom is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biochemistry, medicine, and pharmacology.

Top concepts

Publications per year

1979–2006

49

Publications

49

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

, , +19

Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase

James D. Bergstrom, Richard G. Bostedor, P. Masarachia et al. · Archives of Biochemistry and Biophysics · 2000 · 398 citations

, , +6

Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture

John Edmond, Richard Robbins, James D. Bergstrom et al. · Journal of Neuroscience Research · 1987 · 362 citations

Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.

James D. Bergstrom, Marc M. Kurtz, Deborah J. Rew et al. · Proceedings of the National Academy of Sciences · 1993 · 334 citations · Full text

, , +9

Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

M J Forrest, S.-Y. Sun, Richard Hajdu et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 332 citations

Rows per page

1–5 of 49